Hospira, Inc.
Headquarters
275 North Field Drive
Lake Forest
Illinois
60045
U.S.A.
Phone:
224-212-2000
Fax:
n/a
|
|
Hospira is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™ by developing, manufacturing and marketing products that improve the productivity, safety and efficacy of patient care. Created from the core global hospital products business of Abbott Laboratories in April 2004, Hospira has a 70-year history of service to the hospital industry.
In February 2007, Hospira acquired Mayne Pharma Limited to become the world leader in specialty generic injectable pharmaceuticals. Through its offering of high-quality, lower-cost alternatives to proprietary medications, Hospira continues to help reduce the overall costs of healthcare – to improve both the affordability of care for patients and the financial strength of the global healthcare system. The company also is a pioneer in providing innovative solutions to improve patient and healthcare worker safety. Its portfolio includes one of the industry's broadest lines of generic acutecare and oncology injectables, and integrated solutions for medication management and infusion therapy.
OPERATIONS
Nine manufacturing facilities in the United States include: Ashland, Ohio; Austin, Texas; Boulder, Colo.; Buffalo, N.Y.; Clayton, N.C.; McPherson, Kan.; Morgan Hill, Calif.; Rocky Mount, N.C.; and part of the Abbott facility in North Chicago, Ill. Nine facilities outside the United States include: Aguadilla, Puerto Rico; Haina, Dominican Republic; La Aurora de Heredia, Costa Rica; Liscate, Italy; Montreal, Canada; Mulgrave, Australia; Salisbury, Australia; Sligo, Ireland; and Wasserburg, Germany.
COMPANY LEADERSHIP
Christopher B. Begley, Chief Executive Officer
David A. Jones, Chairman (Co-founder and Chairman Emeritus of Humana Inc.)
CUSTOMERS
Hospira has established long-standing customer relationships that span the "continuum of care" (hospitals, alternate site facilities, home healthcare providers and long-term care facilities).
MAJOR BUSINESSES/PRODUCTS
Hospira has a leading position in the manufacture and supply of a broad range of hospital products including:
Specialty injectables (including generic acute-care and oncology injectables, intensive-care proprietary pharmaceuticals, as well as proprietary delivery systems such as the iSecure™ syringe, a pre-filled, ready-to-use, disposable syringe)
Medication management systems (including electronic infusion pumps and the Hospira MedNet® software system)
Infusion therapy solutions/supplies (including the VisIV™ next-generation container)
Critical care devices
Third-party contract manufacturing, which leverages Hospira's expertise in pharmaceutical manufacturing
Hospira's news releases and other information can be found at www.hospira.com.
Email:
Ownership:
Web Site:
Hospira, Inc.
Employees:
Approximately 15,000 employees worldwide
Symbol: HSP
|
|
|
Company News |
Hospira, Inc. (HSP) Names Daphne E. Jones Chief Information Officer
10/20/2009 10:54:35 AM
More...
|
FDA Warns Faulty Plugs On Hospira, Inc. (HSP) And Abbott Laboratories (ABT) Devices May Cause Sparks and Fires
10/20/2009 7:30:01 AM
More...
|
U.S. FDA Probing Abbott Laboratories (ABT) (JOBS), Hospira, Inc. (HSP) (JOBS) Device Cords
10/20/2009 7:29:10 AM
More...
|
Hospira, Inc. (HSP) to Present at Credit Suisse First Boston 18th Annual Healthcare Conference Nov. 11
10/13/2009 8:54:54 AM
More...
|
Hospira, Inc. (HSP) (JOBS) in Deal with Celltrion, Inc. on Biogenerics
10/9/2009 6:48:11 AM
More...
|
Hospira, Inc. (HSP), Celltrion, Inc. Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
10/8/2009 11:15:41 AM
More...
|
Hospira, Inc. (HSP) (JOBS) Gains Global Biogeneric Rights from Teva Pharmaceutical Industries Limited (TEVA) (JOBS)
9/30/2009 8:21:16 AM
More...
|
Hospira, Inc. (HSP) to Host Conference Call for Third-Quarter 2009 Results
9/29/2009 8:14:54 AM
More...
|
Hospira, Inc. (HSP): Cancer Experts Urge Adherence To Revised International Guidelines On Use Of ESAs In Treatment Of Chemotherapy-Induced Anaemia
9/22/2009 2:25:35 PM
More...
|
Hospira, Inc. (HSP): Erythropoietins In Oncology – An Interactive Review Of Current Thinking
9/21/2009 2:25:00 PM
More...
|
|
|
|